PMC:7441788 / 4366-4609 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T44","span":{"begin":32,"end":40},"obj":"Disease"},{"id":"T45","span":{"begin":98,"end":107},"obj":"Disease"},{"id":"T46","span":{"begin":159,"end":167},"obj":"Disease"}],"attributes":[{"id":"A44","pred":"mondo_id","subj":"T44","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A45","pred":"mondo_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A46","pred":"mondo_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"and SI\u003e3, respectively [10,11]. SARS-CoV replication was inhibited by 99% at 16 μM CQ 3 days post-infection [12]. The data indicates that CQ has stronger anti-SARS-CoV activity than HCQ. In addition, CQ has both a prophylactic and a therapeuti"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T35","span":{"begin":141,"end":144},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T36","span":{"begin":168,"end":176},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T37","span":{"begin":203,"end":206},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T38","span":{"begin":212,"end":213},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T39","span":{"begin":231,"end":232},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"and SI\u003e3, respectively [10,11]. SARS-CoV replication was inhibited by 99% at 16 μM CQ 3 days post-infection [12]. The data indicates that CQ has stronger anti-SARS-CoV activity than HCQ. In addition, CQ has both a prophylactic and a therapeuti"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T52","span":{"begin":4,"end":6},"obj":"Chemical"},{"id":"T53","span":{"begin":83,"end":85},"obj":"Chemical"},{"id":"T54","span":{"begin":138,"end":140},"obj":"Chemical"},{"id":"T55","span":{"begin":200,"end":202},"obj":"Chemical"}],"attributes":[{"id":"A52","pred":"chebi_id","subj":"T52","obj":"http://purl.obolibrary.org/obo/CHEBI_90326"},{"id":"A53","pred":"chebi_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"},{"id":"A54","pred":"chebi_id","subj":"T54","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"},{"id":"A55","pred":"chebi_id","subj":"T55","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"}],"text":"and SI\u003e3, respectively [10,11]. SARS-CoV replication was inhibited by 99% at 16 μM CQ 3 days post-infection [12]. The data indicates that CQ has stronger anti-SARS-CoV activity than HCQ. In addition, CQ has both a prophylactic and a therapeuti"}

{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T33","span":{"begin":83,"end":85},"obj":"Chemical"},{"id":"T34","span":{"begin":138,"end":140},"obj":"Chemical"},{"id":"T35","span":{"begin":200,"end":202},"obj":"Chemical"}],"attributes":[{"id":"A33","pred":"chebi_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"},{"id":"A34","pred":"chebi_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"},{"id":"A35","pred":"chebi_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"}],"text":"and SI\u003e3, respectively [10,11]. SARS-CoV replication was inhibited by 99% at 16 μM CQ 3 days post-infection [12]. The data indicates that CQ has stronger anti-SARS-CoV activity than HCQ. In addition, CQ has both a prophylactic and a therapeuti"}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T44","span":{"begin":32,"end":40},"obj":"Species"},{"id":"T45","span":{"begin":159,"end":167},"obj":"Species"}],"attributes":[{"id":"A44","pred":"ncbi_taxonomy_id","subj":"T44","obj":"NCBItxid:694009"},{"id":"A45","pred":"ncbi_taxonomy_id","subj":"T45","obj":"NCBItxid:694009"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"and SI\u003e3, respectively [10,11]. SARS-CoV replication was inhibited by 99% at 16 μM CQ 3 days post-infection [12]. The data indicates that CQ has stronger anti-SARS-CoV activity than HCQ. In addition, CQ has both a prophylactic and a therapeuti"}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T37","span":{"begin":32,"end":113},"obj":"Sentence"},{"id":"T38","span":{"begin":114,"end":186},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"and SI\u003e3, respectively [10,11]. SARS-CoV replication was inhibited by 99% at 16 μM CQ 3 days post-infection [12]. The data indicates that CQ has stronger anti-SARS-CoV activity than HCQ. In addition, CQ has both a prophylactic and a therapeuti"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"197","span":{"begin":80,"end":82},"obj":"Gene"},{"id":"201","span":{"begin":32,"end":40},"obj":"Species"},{"id":"203","span":{"begin":159,"end":167},"obj":"Species"},{"id":"206","span":{"begin":83,"end":85},"obj":"Chemical"},{"id":"207","span":{"begin":138,"end":140},"obj":"Chemical"},{"id":"208","span":{"begin":182,"end":185},"obj":"Chemical"},{"id":"209","span":{"begin":200,"end":202},"obj":"Chemical"},{"id":"211","span":{"begin":98,"end":107},"obj":"Disease"}],"attributes":[{"id":"A207","pred":"pubann:denotes","subj":"207","obj":"MESH:D002738"},{"id":"A197","pred":"pubann:denotes","subj":"197","obj":"Gene:56925"},{"id":"A208","pred":"pubann:denotes","subj":"208","obj":"MESH:D006886"},{"id":"A206","pred":"pubann:denotes","subj":"206","obj":"MESH:D002738"},{"id":"A209","pred":"pubann:denotes","subj":"209","obj":"MESH:D002738"},{"id":"A211","pred":"pubann:denotes","subj":"211","obj":"MESH:D007239"},{"id":"A201","pred":"pubann:denotes","subj":"201","obj":"Tax:694009"},{"id":"A203","pred":"pubann:denotes","subj":"203","obj":"Tax:694009"}],"text":"and SI\u003e3, respectively [10,11]. SARS-CoV replication was inhibited by 99% at 16 μM CQ 3 days post-infection [12]. The data indicates that CQ has stronger anti-SARS-CoV activity than HCQ. In addition, CQ has both a prophylactic and a therapeuti"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T32","span":{"begin":41,"end":52},"obj":"http://purl.obolibrary.org/obo/IDO_0000608"},{"id":"T33","span":{"begin":98,"end":107},"obj":"http://purl.obolibrary.org/obo/IDO_0000586"}],"text":"and SI\u003e3, respectively [10,11]. SARS-CoV replication was inhibited by 99% at 16 μM CQ 3 days post-infection [12]. The data indicates that CQ has stronger anti-SARS-CoV activity than HCQ. In addition, CQ has both a prophylactic and a therapeuti"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T38","span":{"begin":32,"end":40},"obj":"Disease"},{"id":"T39","span":{"begin":98,"end":107},"obj":"Disease"},{"id":"T40","span":{"begin":159,"end":167},"obj":"Disease"}],"attributes":[{"id":"A38","pred":"mondo_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A39","pred":"mondo_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A40","pred":"mondo_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"and SI\u003e3, respectively [10,11]. SARS-CoV replication was inhibited by 99% at 16 μM CQ 3 days post-infection [12]. The data indicates that CQ has stronger anti-SARS-CoV activity than HCQ. In addition, CQ has both a prophylactic and a therapeuti"}

{"project":"LitCovid-PubTator","denotations":[{"id":"197","span":{"begin":80,"end":82},"obj":"Gene"},{"id":"201","span":{"begin":32,"end":40},"obj":"Species"},{"id":"203","span":{"begin":159,"end":167},"obj":"Species"},{"id":"206","span":{"begin":83,"end":85},"obj":"Chemical"},{"id":"207","span":{"begin":138,"end":140},"obj":"Chemical"},{"id":"208","span":{"begin":182,"end":185},"obj":"Chemical"},{"id":"209","span":{"begin":200,"end":202},"obj":"Chemical"},{"id":"211","span":{"begin":98,"end":107},"obj":"Disease"}],"attributes":[{"id":"A197","pred":"tao:has_database_id","subj":"197","obj":"Gene:56925"},{"id":"A201","pred":"tao:has_database_id","subj":"201","obj":"Tax:694009"},{"id":"A203","pred":"tao:has_database_id","subj":"203","obj":"Tax:694009"},{"id":"A206","pred":"tao:has_database_id","subj":"206","obj":"MESH:D002738"},{"id":"A207","pred":"tao:has_database_id","subj":"207","obj":"MESH:D002738"},{"id":"A208","pred":"tao:has_database_id","subj":"208","obj":"MESH:D006886"},{"id":"A209","pred":"tao:has_database_id","subj":"209","obj":"MESH:D002738"},{"id":"A211","pred":"tao:has_database_id","subj":"211","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"and SI\u003e3, respectively [10,11]. SARS-CoV replication was inhibited by 99% at 16 μM CQ 3 days post-infection [12]. The data indicates that CQ has stronger anti-SARS-CoV activity than HCQ. In addition, CQ has both a prophylactic and a therapeuti"}

{"project":"LitCovid-sentences","denotations":[{"id":"T37","span":{"begin":32,"end":113},"obj":"Sentence"},{"id":"T38","span":{"begin":114,"end":186},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"and SI\u003e3, respectively [10,11]. SARS-CoV replication was inhibited by 99% at 16 μM CQ 3 days post-infection [12]. The data indicates that CQ has stronger anti-SARS-CoV activity than HCQ. In addition, CQ has both a prophylactic and a therapeuti"}

{"project":"2_test","denotations":[{"id":"32496926-24841269-132195657","span":{"begin":24,"end":26},"obj":"24841269"},{"id":"32496926-16640347-132195658","span":{"begin":27,"end":29},"obj":"16640347"},{"id":"32496926-15351731-132195659","span":{"begin":109,"end":111},"obj":"15351731"}],"text":"and SI\u003e3, respectively [10,11]. SARS-CoV replication was inhibited by 99% at 16 μM CQ 3 days post-infection [12]. The data indicates that CQ has stronger anti-SARS-CoV activity than HCQ. In addition, CQ has both a prophylactic and a therapeuti"}